These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 20855727)
1. Safety and efficacy of moxifloxacin monotherapy for treatment of orthopedic implant-related staphylococcal infections. San Juan R; Garcia-Reyne A; Caba P; Chaves F; Resines C; Llanos F; López-Medrano F; Lizasoain M; Aguado JM Antimicrob Agents Chemother; 2010 Dec; 54(12):5161-6. PubMed ID: 20855727 [TBL] [Abstract][Full Text] [Related]
2. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. Foreign-Body Infection (FBI) Study Group. Zimmerli W; Widmer AF; Blatter M; Frei R; Ochsner PE JAMA; 1998 May; 279(19):1537-41. PubMed ID: 9605897 [TBL] [Abstract][Full Text] [Related]
3. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance. Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of antibiotic treatment of implant-associated Greimel F; Scheuerer C; Gessner A; Simon M; Kalteis T; Grifka J; Benditz A; Springorum HR; Schaumburger J Drug Des Devel Ther; 2017; 11():1729-1736. PubMed ID: 28652709 [TBL] [Abstract][Full Text] [Related]
5. Moxifloxacin plus rifampin as an alternative for levofloxacin plus rifampin in the treatment of a prosthetic joint infection with Staphylococcus aureus. Wouthuyzen-Bakker M; Tornero E; Morata L; Nannan Panday PV; Jutte PC; Bori G; Kampinga GA; Soriano A Int J Antimicrob Agents; 2018 Jan; 51(1):38-42. PubMed ID: 28668678 [TBL] [Abstract][Full Text] [Related]
6. Levofloxacin plus rifampicin conservative treatment of 25 early staphylococcal infections of osteosynthetic devices for rigid internal fixation. Barberán J; Aguilar L; Giménez MJ; Carroquino G; Granizo JJ; Prieto J Int J Antimicrob Agents; 2008 Aug; 32(2):154-7. PubMed ID: 18571387 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of ciprofloxacin, levofloxacin, or moxifloxacin for treatment of experimental Staphylococcus aureus keratitis. Dajcs JJ; Thibodeaux BA; Marquart ME; Girgis DO; Traidej M; O'Callaghan RJ Antimicrob Agents Chemother; 2004 Jun; 48(6):1948-52. PubMed ID: 15155183 [TBL] [Abstract][Full Text] [Related]
9. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Drancourt M; Stein A; Argenson JN; Zannier A; Curvale G; Raoult D Antimicrob Agents Chemother; 1993 Jun; 37(6):1214-8. PubMed ID: 8328772 [TBL] [Abstract][Full Text] [Related]
10. [Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci]. Hidalgo M; Reyes J; Cárdenas AM; Díaz L; Rincón S; Vanegas N; Díaz PL; Castañeda E; Arias CA Biomedica; 2008 Jun; 28(2):284-94. PubMed ID: 18719726 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of moxifloxacin compared to teicoplanin in the treatment of implant-related chronic osteomyelitis in rats. Ozturan KE; Yucel I; Kocoglu E; Cakici H; Guven M J Orthop Res; 2010 Oct; 28(10):1368-72. PubMed ID: 20839321 [TBL] [Abstract][Full Text] [Related]
12. Biofilm formation is not necessary for development of quinolone-resistant "persister" cells in an attached Staphylococcus epidermidis population. Knobloch JK; Von Osten H; Horstkotte MA; Rohde H; Mack D Int J Artif Organs; 2008 Sep; 31(9):752-60. PubMed ID: 18924086 [TBL] [Abstract][Full Text] [Related]
13. Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapy. Tarasi A; Cassone M; Monaco M; Tarasi D; Pompeo ME; Venditti M J Chemother; 2003 Jun; 15(3):239-43. PubMed ID: 12868549 [TBL] [Abstract][Full Text] [Related]
14. In vivo efficacy of moxifloxacin compared with cloxacillin and vancomycin in a Staphylococcus aureus rabbit arthritis experimental model. Grossi O; Caillon J; Arvieux C; Jacqueline C; Bugnon D; Potel G; Hamel A Antimicrob Agents Chemother; 2007 Sep; 51(9):3401-3. PubMed ID: 17576849 [TBL] [Abstract][Full Text] [Related]
15. Treatment of implant-associated infections with moxifloxacin: an animal study. Kalteis T; Beckmann J; Schröder HJ; Schaumburger J; Linde HJ; Lerch K; Lehn N Int J Antimicrob Agents; 2006 May; 27(5):444-8. PubMed ID: 16621461 [TBL] [Abstract][Full Text] [Related]
16. Two-stage treatment of chronic staphylococcal orthopaedic implant-related infections using vancomycin impregnated PMMA spacer and rifampin containing antibiotic protocol. Isiklar ZU; Demirörs H; Akpinar S; Tandogan RN; Alparslan M Bull Hosp Jt Dis; 1999; 58(2):79-85. PubMed ID: 10509199 [TBL] [Abstract][Full Text] [Related]
18. Fluoroquinolone susceptibilities to methicillin-resistant and susceptible coagulase-negative Staphylococcus isolated from eye infection. Oliveira AD; Höfling-Lima AL; Belfort R; Gayoso Mde F; Francisco W Arq Bras Oftalmol; 2007; 70(2):286-9. PubMed ID: 17589701 [TBL] [Abstract][Full Text] [Related]
19. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis. DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487 [TBL] [Abstract][Full Text] [Related]
20. Moxifloxacin-rifampicin combination for the treatment of non-staphylococcal Gram-positive orthopedic implant-related infections. Fily F; Jolivet-Gougeon A; Polard E; Gicquel T; Dupont M; Verdier MC; Arvieux C Med Mal Infect; 2019 Oct; 49(7):540-544. PubMed ID: 31277834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]